| Insurance Australia Group Limited (IAG) ORDINARY FULLY PAID |
Financials |
$21,169 |
IAG prices wholesale subordinated note issue
|
26 Feb 2025 3:22PM |
$7.830 |
$8.950 |
risen by
14.30%
|
|
| Universal Biosensors, Inc. (UBI) CHESS DEPOSITARY INTERESTS 1:1 |
Health Care |
$10 |
FY2024 Annual Results Presentation
|
26 Feb 2025 3:21PM |
$0.074 |
$0.035 |
fallen by
52.70%
|
|
UBI - Price-sensitive ASX Announcement
Full Release
Key Points
- UBI has launched nine market-leading products in the last four years.
- More than 15 billion tests have been delivered globally using UBI's technology.
- Two new products focused on environmental testing are set to launch in H1 2025.
- Xprecia Prime received FDA approval and has seen first sales in the US.
- Revenue from wine testing products has shown significant growth despite challenges.
- AQUASCOUT is a new handheld water testing device for lead and copper detection.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Far East Gold Ltd (FEG) ORDINARY FULLY PAID |
Materials |
$57 |
Change in substantial holding
|
26 Feb 2025 3:18PM |
$0.165 |
$0.155 |
fallen by
6.06%
|
|
| Syntara Limited (SNT) ORDINARY FULLY PAID |
Health Care |
$86 |
Half Year Report and Appendix 4D
|
26 Feb 2025 3:18PM |
$0.082 |
$0.053 |
fallen by
35.37%
|
|
SNT - Price-sensitive ASX Announcement
Full Release
Key Points
- Syntara Limited's half-year report shows a revenue increase of 337.94% to $3,070,000.
- Loss attributable to owners decreased by 54.3% to $2,716,000.
- Focus on lead drug candidate SNT-5505 for myelofibrosis with FDA Orphan Drug Designation.
- Progressing clinical studies for myelodysplastic syndrome and scarring treatments.
- No dividends were paid, recommended, or declared during the current financial period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Universal Biosensors, Inc. (UBI) CHESS DEPOSITARY INTERESTS 1:1 |
Health Care |
$10 |
FY2024 Appendix 4G and Corporate Governance Statement
|
26 Feb 2025 3:16PM |
$0.074 |
$0.035 |
fallen by
52.70%
|
|
| Technology One Limited (TNE) ORDINARY FULLY PAID |
Information Technology |
$13,275 |
Notification regarding unquoted securities - TNE
|
26 Feb 2025 3:16PM |
$31.040 |
$40.550 |
risen by
30.64%
|
|
| Universal Biosensors, Inc. (UBI) CHESS DEPOSITARY INTERESTS 1:1 |
Health Care |
$10 |
Appendix 4E and Annual Report FY2024
|
26 Feb 2025 3:15PM |
$0.074 |
$0.035 |
fallen by
52.70%
|
|
UBI - Price-sensitive ASX Announcement
Full Release
Key Points
- UBI received FDA approval for its Xprecia Prime Coagulation Analyzer.
- The company raised A$10 million through a fully underwritten rights issue.
- UBI is focused on expanding its biosensor technology.
- The company operates under strict regulatory compliance.
- Key products are targeted towards human health, veterinary, and wine industries.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Whitehaven Coal Limited (WHC) ORDINARY FULLY PAID |
Energy |
$4,869 |
Appendix 3Y - Mark Vaile
|
26 Feb 2025 3:13PM |
$5.755 |
$5.820 |
risen by
1.13%
|
|
| Livium Ltd (LIT) ORDINARY FULLY PAID |
Industrials |
$15 |
Proposed issue of securities - LIT
|
26 Feb 2025 3:00PM |
$0.015 |
$0.009 |
fallen by
37.93%
|
|
| Gryphon Capital Income Trust (GCI) ORDINARY UNITS FULLY PAID |
Financials |
$1,064 |
Net Tangible Asset Backing
|
26 Feb 2025 2:58PM |
$2.030 |
$2.030 |
fallen by
0%
|
|
| Livium Ltd (LIT) ORDINARY FULLY PAID |
Industrials |
$15 |
Update - Proposed issue of securities - LIT
|
26 Feb 2025 2:50PM |
$0.015 |
$0.009 |
fallen by
37.93%
|
|
| Charter Hall Group (CHC) STAPLED SECURITIES US PROHIBITED |
Real Estate |
$9,205 |
Fund Payment Notice
|
26 Feb 2025 2:43PM |
$17.320 |
$19.460 |
risen by
12.36%
|
|
| Volt Resources Limited (VRC) ORDINARY FULLY PAID |
Materials |
$23 |
Response to ASX Price and Volume Query
|
26 Feb 2025 2:41PM |
$0.005 |
$0.005 |
fallen by
0%
|
|
VRC - Price-sensitive ASX Announcement
Full Release
Key Points
- Volt Resources is responding to an ASX query about trading price and volume.
- The company's securities increased from $0.003 to $0.005.
- VRC is not aware of any undisclosed information that could explain recent trading.
- Recent news highlights a critical minerals deal between Ukraine and the US.
- The deal is expected to positively impact VRC's operations at Zavalievsky Graphite mine.
- VRC confirms compliance with ASX Listing Rules.
- All responses to ASX queries were authorized by the board.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Growthpoint Properties Australia (GOZ) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,870 |
GOZ fund payment notice (foreign residents)
|
26 Feb 2025 2:38PM |
$2.410 |
$2.480 |
risen by
2.90%
|
|
| Star Combo Pharma Limited (S66) ORDINARY FULLY PAID |
Consumer Staple |
$18 |
S66 Dec 2024 Half Year Report & Financial Statements
|
26 Feb 2025 2:36PM |
$0.185 |
$0.135 |
fallen by
27.03%
|
|
S66 - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 28% to $15,749,723.
- Operating profit after tax rose by 120% to $276,342.
- Total comprehensive income attributable to shareholders was $261,693, up 154% from the previous year.
- OEM division revenue increased by 50% to $11.29 million.
- Retail sales fell by 28.5% to $1,112,973.
- No dividends were paid or declared during the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cosmo Metals Limited (CMO) ORDINARY FULLY PAID |
Materials |
$5 |
Letter to Shareholders - Notice of GM
|
26 Feb 2025 2:31PM |
$0.022 |
$0.017 |
fallen by
22.73%
|
|
| JB Hi-Fi Limited (JBH) ORDINARY FULLY PAID |
Consumer Discretionary |
$12,023 |
Update - Dividend/Distribution - JBH
|
26 Feb 2025 2:30PM |
$91.355 |
$109.970 |
risen by
20.38%
|
|
| Cosmo Metals Limited (CMO) ORDINARY FULLY PAID |
Materials |
$5 |
Notice of General Meeting/Proxy Form
|
26 Feb 2025 2:30PM |
$0.022 |
$0.017 |
fallen by
22.73%
|
|
| Sparc Technologies Limited (SPN) ORDINARY FULLY PAID |
Materials |
$18 |
Appendix 4D and Half Yearly Report and Accounts
|
26 Feb 2025 2:28PM |
$0.205 |
$0.155 |
fallen by
24.39%
|
|
SPN - Price-sensitive ASX Announcement
Full Release
Key Points
- Sparc Technologies recorded a loss after tax of $802,190 for the half-year ended 31 December 2024.
- Loss reduced compared to $2,058,806 for the same period in 2023.
- The company focuses on research and development of innovative technologies.
- No dividends were paid or recommended during the half-year.
- Working capital decreased to $1,609,205 from $3,035,073 in the previous year.
- The group experienced negative cash flows from operating activities amounting to $399,876.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mayur Resources Limited (MRL) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$200 |
Application for quotation of securities - MRL
|
26 Feb 2025 2:28PM |
$0.295 |
$0.245 |
fallen by
16.95%
|
|
| Prophecy International Holdings Limited (PRO) ORDINARY FULLY PAID |
Information Technology |
$34 |
Half Year Accounts
|
26 Feb 2025 2:24PM |
$0.480 |
$0.458 |
fallen by
4.69%
|
|
PRO - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased to $11.6 million in H1 FY25, up 1% year-on-year.
- Contracted annualised recurring revenue (ARR) reached $25.9 million.
- Company focused on organic growth through emite and Snare product lines.
- Transition towards subscription-based revenue model for Snare continued.
- Increased cash consumption due to investments in product development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Diablo Resources Limited (DBO) ORDINARY FULLY PAID |
Materials |
$2 |
Cleansing Notice
|
26 Feb 2025 2:23PM |
$0.019 |
$0.015 |
fallen by
21.05%
|
|
| Diablo Resources Limited (DBO) ORDINARY FULLY PAID |
Materials |
$2 |
Application for quotation of securities - DBO
|
26 Feb 2025 2:21PM |
$0.019 |
$0.015 |
fallen by
21.05%
|
|
| Respiri Limited (RSH) ORDINARY FULLY PAID |
Health Care |
- |
Appendix 4D and Half Year Financial Report
|
26 Feb 2025 2:16PM |
$0.048 |
$0.033 |
fallen by
31.25%
|
|
RSH - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 111.3% to $1,544,246 from $730,832.
- Net loss after tax attributable to members was $3,639,648.
- Patient program engagements rose to 4,063, a 67% increase over the previous quarter.
- 63% of billable services were for Remote Patient Monitoring.
- The successful acquisition of Orb Health adds significant value and revenue potential.
- The company expects further growth in patient volumes and revenue in 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pilot Energy Limited (PGY) ORDINARY FULLY PAID |
Energy |
$13 |
Response to ASX Aware Query
|
26 Feb 2025 2:13PM |
$0.005 |
$0.006 |
risen by
20%
|
|
PGY - Price-sensitive ASX Announcement
Full Release
Key Points
- PGY is engaged in a joint feasibility study with South32.
- The study was committed to in September 2024.
- The feasibility study commenced in February 2025.
- The study is expected to complete in Q3 CY 2025.
- PGY confirmed compliance with ASX Listing Rules.
- The agreement regarding the study is non-binding and confidential.
- Costs for the study are funded through a Carbon Capture technologies program grant.
- The arrangement has a one-year term with mutual termination rights.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
